Nivolumab in relapsed refractory Hodgkin Lymphoma

E-session 400 / CME accredited Add to My Agenda


Astrid Pavlovsky, expert of session 'Nivolumab in relapsed refractory Hodgkin Lymphoma'

Astrid Pavlovsky
Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

Discussant: Emanuele Zucca
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

View slides

Enter the recorded session

Share on:

In order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed

Check the minimum system requirements

Jun 2017
18:15-19:00 CET